These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 36907598)
1. A comparative analysis of daunorubicin and its metabolite daunorubicinol interaction with apoptotic and drug resistance proteins using Rai AK; Satija NK J Biomol Struct Dyn; 2023 Dec; 41(20):10737-10749. PubMed ID: 36907598 [TBL] [Abstract][Full Text] [Related]
2. Targeted inhibition of ULK1 enhances daunorubicin sensitivity in acute myeloid leukemia. Qiu L; Zhou G; Cao S Life Sci; 2020 Feb; 243():117234. PubMed ID: 31887299 [TBL] [Abstract][Full Text] [Related]
3. Susceptibility of idarubicin, daunorubicin, and their C-13 alcohol metabolites to transport-mediated multidrug resistance. Ross DD; Doyle LA; Yang W; Tong Y; Cornblatt B Biochem Pharmacol; 1995 Nov; 50(10):1673-83. PubMed ID: 7503771 [TBL] [Abstract][Full Text] [Related]
4. [Embelin Reverses the Multi-drug Resistance of K562/D to Daunorubicin Independently of P-gp and MDR1 mRNA]. Jiang HN; Liu ZG; Hu R Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1342-1349. PubMed ID: 29070105 [TBL] [Abstract][Full Text] [Related]
5. Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells. Rao J; Xu DR; Zheng FM; Long ZJ; Huang SS; Wu X; Zhou WH; Huang RW; Liu Q J Transl Med; 2011 May; 9():71. PubMed ID: 21595920 [TBL] [Abstract][Full Text] [Related]
6. Two distinct modes of oncoprotein expression during apoptosis resistance in vincristine and daunorubicin multidrug-resistant HL60 cells. Belhoussine R; Morjani H; Gillet R; Palissot V; Manfait M Adv Exp Med Biol; 1999; 457():365-81. PubMed ID: 10500812 [TBL] [Abstract][Full Text] [Related]
7. In vitro effect of multidrug resistance modifiers on idarubicinol efflux in blasts of acute myeloid leukemia. Schröder JK; Kasimir-Bauer S; Seeber S; Scheulen ME J Cancer Res Clin Oncol; 2000 Feb; 126(2):111-6. PubMed ID: 10664252 [TBL] [Abstract][Full Text] [Related]
8. NOXA-mediated degradation of MCL1 and BCL2L1 causes apoptosis of daunorubicin-treated human acute myeloid leukemia cells. Chiou JT; Huang NC; Huang CH; Wang LJ; Lee YC; Shi YJ; Chang LS J Cell Physiol; 2021 Nov; 236(11):7356-7375. PubMed ID: 33982799 [TBL] [Abstract][Full Text] [Related]
9. Enhanced potency of daunorubicin against multidrug resistant subline KB-ChR-8-5-11 by a pulsed magnetic field. Liang Y; Hannan CJ; Chang BK; Schoenlein PV Anticancer Res; 1997; 17(3C):2083-8. PubMed ID: 9216668 [TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics of Daunorubicin in adult patients with acute myeloid leukemia. Varatharajan S; Panetta JC; Abraham A; Karathedath S; Mohanan E; Lakshmi KM; Arthur N; Srivastava VM; Nemani S; George B; Srivastava A; Mathews V; Balasubramanian P Cancer Chemother Pharmacol; 2016 Nov; 78(5):1051-1058. PubMed ID: 27738808 [TBL] [Abstract][Full Text] [Related]
11. New Mechanistic Insight on the PIM-1 Kinase Inhibitor AZD1208 Using Multidrug Resistant Human Erythroleukemia Cell Lines and Molecular Docking Simulations. Marques MB; González-Durruthy M; da Silva Nornberg BF; Oliveira BR; Almeida DV; de Souza Votto AP; Marins LF Curr Top Med Chem; 2019; 19(11):914-926. PubMed ID: 31072293 [TBL] [Abstract][Full Text] [Related]
12. Apoptotic mechanism of human leukemia K562/A02 cells induced by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin. Wang J; Chen B; Cheng J; Cai X; Xia G; Liu R; Wang X Int J Nanomedicine; 2011; 6():1027-34. PubMed ID: 21720514 [TBL] [Abstract][Full Text] [Related]
13. CREB/Sp1-mediated MCL1 expression and NFκB-mediated ABCB1 expression modulate the cytotoxicity of daunorubicin in chronic myeloid leukemia cells. Chiou JT; Huang CH; Wu TH; Wang LJ; Lee YC; Huang PW; Chang LS Toxicol Appl Pharmacol; 2022 Jan; 435():115847. PubMed ID: 34963561 [TBL] [Abstract][Full Text] [Related]
14. Effect of nitric oxide on the daunorubicin efflux mechanism in K562 cells. Curta JC; de Moraes AC; Licínio MA; Costa A; Santos-Silva MC Cell Biol Int; 2012 Jun; 36(6):529-35. PubMed ID: 22360312 [TBL] [Abstract][Full Text] [Related]
15. Influence of Bcl-2 overexpression on the ceramide pathway in daunorubicin-induced apoptosis of leukemic cells. Allouche M; Bettaieb A; Vindis C; Rousse A; Grignon C; Laurent G Oncogene; 1997 Apr; 14(15):1837-45. PubMed ID: 9150390 [TBL] [Abstract][Full Text] [Related]
16. [Inducing apoptosis and reversal effect of nilotinib in combination with tetrandrine on multidrug resistance of K562/A02 cell line]. Cui TY; Chen BA; Ding JH; Gao C; Cheng J; Bao W; Zhong YJ; Shan XY; Gao F; Xia GH; Schmitt A; Schmitt M Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):28-33. PubMed ID: 21362216 [TBL] [Abstract][Full Text] [Related]
17. Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia. Oliveira ML; Rocha A; Nardotto GHB; Pippa LF; Simões BP; Lanchote VL J Pharm Biomed Anal; 2020 Nov; 191():113576. PubMed ID: 32889347 [TBL] [Abstract][Full Text] [Related]
18. Daunorubicin and gambogic acid coloaded cysteamine-CdTe quantum dots minimizing the multidrug resistance of lymphoma in vitro and in vivo. Zhou Y; Wang R; Chen B; Sun D; Hu Y; Xu P Int J Nanomedicine; 2016; 11():5429-5442. PubMed ID: 27799767 [TBL] [Abstract][Full Text] [Related]
19. [Effects of 5-bromotetrandrine and daunorubicin on apoptosis and expression of survivin in K562/A02 cells]. Cai XH; Chen BA; Cheng J; Wang J; Ding JH; Bao W; Zhong YJ; Gao F; Xu WL; Shen HL; Wei HL; Chen J Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):24-7. PubMed ID: 21362215 [TBL] [Abstract][Full Text] [Related]
20. Bcl-2, Bax, and c-Fos expression correlates to RPE cell apoptosis induced by UV-light and daunorubicin. Liang YG; Jorgensen AG; Kaestel CG; Wiencke AK; Lui GM; la Cour MH; Röpke CH; Nissen MH Curr Eye Res; 2000 Jan; 20(1):25-34. PubMed ID: 10611712 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]